Built in partnership with City University, London, THE ASTELLAS INNOVATION DEBATE™ ‘My Health, My Choice’ game gives the public an opportunity to control major aspects of healthcare system design and resulting spend
Chertsey, Surrey, Monday 22nd February 2016
A new online game launched today in conjunction with THE ASTELLAS INNOVATION DEBATE, gives the public, the ‘virtual power’ to determine how they would design the country’s health system and how much they would choose to spend on healthcare in comparison to the Government’s current spending commitments. A recent public survey by Astellas Pharma Europe shows that only 24% of people think the British Government currently spends enough on healthcare. However, with the survey also demonstrating clear misconceptions among the public on how much healthcare costs, the ‘My Health, My Choice’ game is today being launched to help the public better understand the complex relationships between healthcare services and costs.
The My Health, My Choice game as it appears on devices:
The game can be played at http://www.innovationdebate.com/myhealthmychoice
“Underpinning the game is an important question that hasn’t been explored before – how much does it cost to change the main characteristics of a healthcare system” comments Dr Mauro Laudicella, Senior Lecturer in Health Economics at City University London who reviewed the data for the ‘My Health, My Choice’ game. “I haven’t seen anything like this game that looks so boldly at the little known cost implications of the care that we receive from our healthcare systems”.
Although the NHS is ranked as one of the institutions that makes people ‘most proud to be British’, 91% of responders to the Astellas survey believe that healthcare services in the UK are in need of change. In particular, shorter waiting times (36% of respondents) and improved access to medicines (30%) rank most highly as the areas in need of greatest reform. However, the same survey also revealed public misunderstanding about the true cost of care with, for example, three in ten believing that staying in hospital on a general care ward costs less than £99 per day, when the true cost is approximately £303. The ‘My Health, My Choice’ game is designed to show users the impact of making changes to health services.
To allow the public an opportunity to design their own health system in response to these challenges, the ‘My Health, My Choice’ game was built using data from the Organisation for Economic Cooperation and Development (OECD),. The game allows the user to design their healthcare system based on a number of set criteria: the number of hospital beds, nurses, GPs and specialists in the UK. If the player chooses to amend any of the figures from the current baseline, they will be shown the impact on not only the healthcare budget, but patient waiting times for specialist appointments too. The player must then decide how any additional costs are met, from either increasing income tax, or diverting money from other government functions.
Follow the debate on Twitter via @AstellasINNOV8 or #innovatedebate
For more information, please contact:
Astellas Pharma EMEA
Mobile:+44 (0)7786 312 623
About The Astellas Innovation DebateTM:
The annual ASTELLAS INNOVATION DEBATE brings together some of the world’s most progressive thinkers to discuss the role of innovation in addressing the greatest challenges of our time. Previous debates have focused on: innovation in a time of austerity, population ageing, and what the DNA and data revolutions mean for our health. World-leading experts such as Nobel Laureates Professor Sir Andre Geim and Dr Elizabeth Blackburn as well as Lord Robert Winston; Professor John Appleby; Dr Leroy Hood; Baroness Helena Kennedy; Professor Lionel Tarrasenko and Professor Rolf Stahel have tackled some of the biggest challenges affecting science and scientific discovery.
This year, broadcaster and presenter Jonathan Dimbleby will chair a panel of world-leading experts for the fourth ASTELLAS INNOVATION DEBATE – Situation Critical: Making Healthcare Fit for the Future, taking place on Thursday 25th February 2016 at the Royal Institution of Great Britain.
In front of an invited audience of key figures from the worlds of science, medicine, politics and business, they will debate the biggest questions about the future of healthcare. Professor Trish Greenhalgh is a Professor of Primary Care Health Sciences, Nuffield Department of Primary Care Health Sciences, University of Oxford and one of this year’s panellists who will be debating the following critical questions:
- What role can innovation play in the drive for affordable healthcare?
- What can we learn from healthcare reforms in different countries?
- Should we expect less from the state and take more responsibility for our own health?
- Is privatisation the key to improved productivity – or a threat to the principle of healthcare for
- Should we simply pay more tax?
About Astellas Pharma Europe Ltd.
Astellas Pharma Europe Ltd. operates in 40 countries across Europe, the Middle East and Africa, and is the EMEA regional business of Tokyo-based Astellas Pharma Inc (Astellas). Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceuticals. The organisation’s focus is to deliver outstanding R&D and marketing to continue growing in the world pharmaceutical market. Astellas’ presence in Europe also includes an R&D site and three manufacturing plants. The company employs over 4,500 people across the EMEA region.
Dr Laudicella has used the OECD data to model the relationship between health care inputs and expenditure in selected OECD countries. More than 100 variables were extracted from the OECD website under the chapter: Health Resources. In identifying the variables to focus on for the game, Dr Laudicella selected those with available comparable data for five countries with similar health care systems: UK, Netherlands, Italy, France, Spain. These indicators are:
- General Medical Practitioners
- Specialist Medical Practitioners
- Hospital beds
Variables generally differ by definition of health service offered, registration (practising, professionally active, or licensed to practise), type of provider: private or public, type of care long term, acute. Measurements are usually made per 1,000 population, many variables are not populated in all selected countries.
Definition of total expenditure on health: The sum of expenditure on activities that, through application of medical, paramedical, nursing knowledge and technology has the goals of:
- Promoting health and preventing disease
- Curing illness and reducing premature mortality
- Caring for persons affected by chronic illness who require nursing care
- Caring for persons with health-related impairments, disability, and handicaps who require nursing care
- Assisting patients to die with dignity
- Providing and administering public health programmes
- Providing and administering health programmes, health insurance and other funding arrangements
The Total Expenditure on Health collected by the OECD includes the following components:
HC.1 Services of curative care
HC.2 Services of rehabilitative care
HC.3 Services of long-term nursing care
HC.4 Ancillary services to health care
HC.5 Medical goods dispensed to out-patients
HC.1-HC.5 Total expenditure on personal health
HC.6 Services of prevention and public health
HC.7 Health administration and health insurance
HC.6 + HC.7 Total expenditure on collective health
HC.9 Expenditure on services not allocated by function
HC.1-HC.9 Total current expenditure
HC.R.1 Investment (gross capital formation) in health
HC.1-HC.9 + HC.R.1 TOTAL EXPENDITURE ON HEALTH
For the purpose of this project, the total current expenditure on health (HC.1-HC.9) incurred by public funds was used. Public funds include the state, regional and local Government bodies and social security schemes
Definitions of variables used:
General Medical Practitioners (GMPs) – Do not limit their practice to certain disease categories or methods of treatment, and may assume responsibility for the provision of continuing and comprehensive medical care to individuals, families and communities.
Secondary Care 1: Specialist Medical Practitioners (SMPs) – Diagnose, treat and prevent illness, disease, injury, and other physical and mental impairments in humans, using specialised testing, diagnostic, medical, surgical, physical and psychiatric techniques, through application of the principles and procedures of modern medicine. They specialise in certain disease categories, types of patient or methods of treatment and may conduct medical education and research in their chosen areas of specialisation
Secondary Care 2: Nurses – Practising nurses: provide services directly to patients (this is the best indicator available in the UK and Spain)
Professionally Active Nurses: Include practising nurses and other nurses for whom their education is a prerequisite for the execution of the job (best indicator available in Netherlands and France)
Licensed to Practise Nurses – they have completed a programme of nursing education and are qualified and authorised in their country to practise nursing. They include practising and other non-practising nurses (Available in Italy)
Professional Nurses: assume responsibility for the planning and management of the care of patients, including the supervision of other health care workers, working autonomously or in teams with medical doctors and others in the practical application of preventive and curative measures
Associate Professional Nurses: generally work under the supervision of, and in support of implementation of health care, treatment and referral plans established by medical, nursing and other health professionals
Hospital Beds – all hospital beds which are regularly maintained and staffed and immediately available for the care of admitted patients. They Include occupied and unoccupied beds in general hospitals, mental health hospitals, and other specialised hospitals.
Once the variables have been adjusted, the game model looks at the variation in health expenditure that is likely to occur if a game user varies the level of selected health inputs in one of the five countries by a small amount2. Predictions are based on observations from France, Italy, Spain, Netherlands and UK during 2009 – 2013.
An econometric model was used to estimate the relationship between Health Expenditure and Health Input variables. The model identifies the average response of Health Expenditure to variation in Health Inputs as these occur in selected countries over a short interval of time. The Health Expenditure was corrected for variation in purchasing power across different countries, country specific effect, and inflation.